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Title of the study: 
Assessment of outcome of functional endoscopic sinus surgery in patients with chronic sinusitis 
with or without sinonasal polyposis 
 
Objectives and aims of study  
To assess the outcome of functional endoscopic sinus surgery (FESS) in patients with chronic 
sinusitis with or without nasal polyposis using the quality of life assessment instrument SNOT 22 
questionnaire and endoscopic scoring. 
Method of study 
This prospective study was conducted in the Department of ENT at Christian Medical 
College Vellore. Pre and postoperative data was collected from patients undergoing functional 
endoscopic sinus surgery for chronic rhinosinusitis with or without polyposis.  We used a quality 
of life instrument (SNOT 22) along with Lund Kennedy endoscopic scoring and Lund Mackay CT 
scan scoring. Patients were followed up for a minimum of 3 to 6 months postoperatively and at 
the same scoring instruments re‐administered. Descriptive data was analyzed and frequency 
distributions derived. Patients with and without sinonasal polyposis were compared in terms of 
demography as well as SNOT 22, endoscopic and CT scores using Student’s t- test. Pearson’s 
correlation was used to assess the correlation between endoscopic scores and CT scan scores. 
Changes in the SNOT 22 score, symptom specific frequency and endoscopic score after surgery 
were assessed using chi square test of proportions, to see if there was a significant difference in 
scores postoperatively. The frequency of complications following the procedures was also 
assessed. 
Results:  
Of a total of 90 patients who were included in the study, 50 patients came for the follow 
up. There were 37 patients with polyps and 13 patients without polyps. On comparing the pre 
and post operative results of SNOT 22 score, we observed that there was a mean improvement of 
19.8 points in the score overall. Out of 37 patients  in the group with polyps, 31 patients (83.8%) 
improved at least by 9 points postoperatively, while 84% (11/13 patients) improved  by at least 
9 points in the group without polyps. The mean improvement of total SNOT 22 score was 20.8 
in the group with polyps and this was statistically significant (p=0.00). The mean improvement 
of total SNOT 22 score was 17.0 in the group without polyposis and this was also statistically 
significant (p=0.01). Symptoms‐ specific assessment showed a significant improvement for all 
the major symptoms. There was a significant improvement in Lund Kennedy endoscopic scores 
(p=0.03) as well in both the groups of the patients. The improvement in SNOT22 scores and 
endoscopic scores was seen in both patients who underwent primary surgery (p=0.00) as well 
as those who underwent revision surgery (p=0.00). The complication rate was only 2.2%. 
Conclusions 
Functional endoscopic sinus surgery provides a significant quality of life improvement as 
well as symptom specific improvement in patients with sinusitis with or without polyposis. The 
improvement in endoscopic appearances is also corroborated by improved endoscopic scores 
postoperatively. Functional endoscopic sinus surgery is equally effective in primary and revision 
cases. There are few complications and it is a safe procedure in experienced hands.  
Key words: Chronic rhinosinusitis with polyps, Chronic rhinosinusitis without polyps SNOT22, 
Lund Kennedy score, Functional endoscopic sinus surgery outcome, Revision functional 
endoscopic sinus surgery 
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                                       AIMS AND OBJECTIVES 
 
 
 
 To assess the outcome of functional endoscopic sinus surgery (FESS) in patients with chronic 
sinusitis with or without nasal polyposis using the quality of life assessment instrument SNOT 22 
questionnaire as well as postoperative rigid nasal endoscopy. 
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                                     INTRODUCTION 
  
  
Chronic rhinosinusitis is a well recognised clinical syndrome, affecting patients of all ages 
and gender(1). It is a major health problem affecting with significant impact on the quality of 
life, productivity and finances(2). There is a wide geographical variation in the prevalence of 
chronic rhinosinusitis ranging from 1.01% to 16% (2,4) 
 
As per the European Position Paper on Rhinosinusitis and Nasal Polyps 2012 guidelines(5),  
chronic rhino-sinusitis is characterized  by inflammation of the mucous membranes of the 
nasal cavity and the paranasal sinuses, with typical symptoms that persist for more than 12 
weeks  and objective criteria using nasal endoscopic findings and or CT scan findings.  
Typical symptoms include more than or at least 2 symptoms, one of which should be nasal 
blockage/obstruction/congestion/nasal discharge (anterior/posterior), with or without facial 
pain/pressure, reduction/loss of smel1. 
 
Inflammation of the nasal and paranasal mucosa, leads to ostial obstruction and retention of 
secretions, which further leads to secondary infection. Inflammation causes mucociliary 
dysfunction thereby perpetuating the condition. Various local and systemic factors can 
contribute to the pathogenesis of chronic rhino-sinusitis. Chronic sinusitis may be associated 
with nasal polyposis. Sinonasal allergy is often a coincidental finding. 
 
Treatment of chronic sinusitis can be medical or surgical. Medical modalities of the therapy 
include topical steroid sprays, nasal douching with saline and long term antibiotic therapy. 
Historically established surgical techniques for the management of chronic rhinosinusitis 
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include antral lavage, Caldwell Luc procedure, intranasal polypectomy, external or 
transantral ethmoidectomy and external frontal sinus surgery depending on the sinuses 
involved. 
 
However, with the advancement of endoscopic surgical procedures over the past two decades, 
the surgical management of sinusitis has completely changed. Functional endoscopic sinus 
surgery (FESS) is a minimally invasive technique in which the sinus ostia are opened under 
direct visualization, with an aim to restore sinus ventilation and normal function. 
 
FESS has now become a well established surgical modality in the treatment of sinusitis 
refractory to medical treatment. However, there is a conspicuous lack of good surgical 
evidence on the efficacy of this intervention. Hence, we have undertaken this study on 
subjective and objective assessment of outcome of FESS in cases of chronic sinusitis, using 
the QOL instrument SNOT 22 questionnaire and Lund Kennedy endoscopic scoring system.  
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PRESENT KNOWLEDGE AND REVIEW OF 
LITERATURE 
 
ANATOMY OF THE NOSE (6) 
The nasal cavity consists of two irregular fossae on either side of the nasal septum, housed in 
a supporting framework of bone and fibroelastic cartilage. The larger bones in this framework 
contain air filled spaces collectively called as the paranasal sinuses. 
The Nasal Cavity 
The nasal cavity extends from the anterior nares to the posterior choanae, where it becomes 
continuous with the nasopharynx (Fig.1). Vertically it extends from the superior border of the 
hard palate to the cribriform plate and can be divided into 3 regions – the nasal vestibule, the 
respiratory region and the olfactory region. Laterally it is related to the orbital cavity and the 
paranasal sinuses. The paranasal sinuses and the nasolacrimal duct drain into the nasal cavity 
through openings on the lateral wall. 
Each nasal cavity has a roof, a floor, a medial wall and a lateral wall. The roof is narrow from 
side to side and is formed by the nasal bone, frontal bone, cribriform plate of the ethmoid 
bone and the body of the sphenoid (Fig.2). It is horizontal in the centre and slopes anteriorly 
and posteriorly. 
The floor of the nose is flattened antero-posteriorly and is about 7cm length in adults. It is 
formed by the palatine process of the maxilla anteriorly and the horizontal process of the 
palatine bone posteriorly. The medial wall is formed by the nasal septum which has 
membranous, cartilaginous and posterior bony parts (Fig 2). 
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Fig. 1 Diagram showing the sagittal view of the nasal cavity 
and its relationship with the nasopharynx. 
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Fig.2 Diagram showing the roof of the nasal cavity and the 
bones constituting the same. 
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The lateral nasal wall is quadrangular in shape and is anatomically and functionally more 
complex. It is mostly bony and partly membranous. The bony part is constituted by parts of 
maxilla, ethmoid, lacrimal, nasal, palatine and sphenoid bones and the areas of deficiency in 
between is covered by the overlying nasal mucosa(Fig 3). 
 
 
Fig. 3 Sagittal section of the skull showing the bones 
constituting the lateral nasal wall. 
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 On the lateral wall  are the three curved bony shelves called the conchae or the turbinates, 
one above the other projecting into the lumen, dividing it into four air channels (Fig 4).The 
middle and the superior conchae are parts of the ethmoidal labyrinth while the inferior concha 
is a separate bone. The inferior meatus lies between the inferior turbinate and the nasal floor 
while the middle meatus is between inferior and middle turbinate. Between the middle and 
superior turbinate is the superior meatus and spheno-ethmoidal recess lies between the 
superior turbinate and the roof. The inferior meatus has the opening of the nasolacrimal duct 
while the middle meatus has the opening for the maxillary sinus, anterior ethmoids and the 
frontal sinus. The turbinates increase the area of contact with the air and have rich blood 
supply and nerve supply, thereby helping in humidification and regulation of turbulence.  
  
The superior concha is a medial process of the ethmoidal labyrinth above which the sphenoid 
sinus opens via the triangular sphenoethmoidal recess and below which the posterior 
ethmoidal sinuses open into the anterior part of the superior meatus via a variable number of 
apertures. Occasionally there can be a supreme turbinate on the wall of the sphenopalatine 
recess with a supreme meatus below it and can contain an opening of the posterior ethmoidal 
sinus. 
The inferior meatus is the largest meatus lying along almost the whole length of the lateral 
wall. It admits the opening of the naso-lacrimal duct, at the junction of anterior one third and 
middle one third. The inferior turbinate articulates with the nasal surface of the maxilla and 
the perpendicular plate of the palatine bone. 
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Fig.4 Sagittal section showing the configuration of superior, 
middle and inferior turbinates on the lateral wall of the nose. 
 
 
 
 
The middle turbinate is also a part of the ethmoidal labyrinth and articulates posteriorly with 
the perpendicular plate of the palatine bone. Under the turbinate and lateral to it lies the 
middle meatus which is deeper anteriorly (Fig 5). The anterior end of the middle meatus 
forms a shallow fossa above the vestibule called the “atrium ‘’ of the middle meatus. 
Posterior to the middle meatus lies the sphenopalatine foramen which transmits the 
 sphenopalatine artery and, superior nasal and nasopalatine nerves from the pterygopalatine 
fossa. The anatomy of the lateral wa
significance in endoscopic sinus surgery.
 
 
Fig.5 Coronal section showing the middle meatus and the structures within.
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Osteomeatal complex (6,7) 
The osteomeatal complex or osteomeatal unit (Fig 6) refers to a three dimensional area on the 
lateral wall of nose in the middle meatus which includes the maxillary sinus ostium, hiatus 
semilunaris and the ethmoidal infundibulum. It is best appreciated in a view in which the 
middle turbinate has been removed ( Fig. 6). It forms the common pathway for drainage of                                     
secretions from the maxillary and the anterior group of ethmoidal sinuses, and, occasionally, 
the frontal sinus, depending on the insertion of uncinate process. Endoscopic finding of 
mucopus in this region is diagnostic of sinusitis and hence it is the functionality of this area 
which is the aim of functional endoscopic sinus surgery.  
The rounded projection on the lateral wall in the middle meatus is the most constant and the 
largest ethmoidal air cell called the bulla ethmoidalis (Fig.6). Anterior to the bulla is the 
uncinate process, which is a thin sagitally oriented bony leaflet of the ethmoidal labyrinth 
(Fig7). It is a “boomerang” shaped bone extending from the lacrimal bone to the bulla. 
Between the free posterior concave margin of the uncinate and the bulla ethmoidalis is a 1 to 
2mm wide, two dimensional, sagittally oriented cleft called the hiatus semilunaris (Figs. 6 & 
7). The infundibulum is a slit like space extending from the hiatus and leading to the 
maxillary ostium. It may measure upto 4cm in length, with a height of 12mm and width of 5 
to 6mm. Medially it is related to the uncinate process in its entire length while laterally it is 
related to the lamina papyracea, frontal process of the maxilla, the lacrimal bone and the 
posterior fontanelle. Posteriorly is the bulla ethmoidalis while the superior relationship 
largely depends on the attachment of the uncinate process. 
The attachment of the middle turbinate to the lateral wall of nose is initially vertical, then 
oblique and, finally, horizontal. This attachment is best seen on a sagittal section of the skull 
with the middle turbinate excised (Fig. 6 and 7). This attachment has special significance in 
that the oblique attachment of the middle turbinate (also known as the ground lamella or 
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basal lamella) separates the anterior ethmoidal air cells from the posterior group. 
Posterosuperior to the bulla and anterior to the ground lamella of the middle turbinate is a 
cleft like space which is known as the lateral sinus or the sinus lateralis of Grunwald. This 
sinus can extend further upto the frontal recess. The cleft between the posterior wall of the 
bulla and the ground lamella, connecting the sinus lateralis to the middle meatus is called the 
hiatus semilunaris superior(10).  
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ANATOMY OF PARANASAL SINUSES (6) 
Four paired paranasal sinuses - the frontal, ethmoidal, maxillary and sphenoid sinuses (Fig 
5,6,7) are housed within the bones of nasal framework. Most sinuses are absent at birth and 
enlarge appreciably during the eruption of the permanent teeth and after puberty. All the 
sinuses drain into the nasal cavity via small apertures which helps in ventilation of the sinuses 
as well as clearance of the mucus. They add resonance to the voice and also allow the 
enlargement of local areas of the skull, sculpturing the facial features, while minimizing a 
corresponding increase in bony mass.  
 
Frontal Sinus 
The paired frontal sinuses lie between the outer and inner tables of the frontal bone below the 
triangular area on the forehead between the nasion, 3cm above the nasion and junction 
between the medial 1/3 and lateral 2/3 of the supraorbital margin on either side. The two 
sinuses are rarely symmetrical, with a septum in between. It is usually absent at birth and 
reaches full size only after puberty with an average adult dimensions of  2.6 cm x1.8 cm x 3.2 
cm. The frontal sinus drains into the anterior part of the middle meatus either as a frontonasal 
recess (rather than a duct) (50 %) or medial to the hiatus semilunaris if the uncinate process is 
attached to the lateral nasal wall or an agger nasi cell (50%).  
 
Ethmoidal Sinus 
The ethmoid bone is a paired bony scaffold held together with a horizontal plate called the 
cribriform plate. The ethmoidal sinuses are formed of multiple thin-walled cavities in the 
ethmoidal labyrinth. The number and size of the cavities varies, from 3 large to 18 small 
sinuses on each side. They are separated from the orbit by the paper-thin lamina papyracea or 
orbital plate of the ethmoid  and is usually the site of spread of infection to orbit especially in 
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children as these sinuses are well developed at birth. Pneumatization may extend into the 
middle concha (30 %), which is known as concha bullosa (Fig 8) or into the body and wings 
of the sphenoid bone lateral to the sphenoid sinus (Onodi cell) (Fig 9 ).  
The ethmoidal sinuses are divided clinically into anterior and posterior groups on each side, 
distinguished by their sites of communication with the nasal cavity. The anterior and 
posterior groups are separated from each other by the basal lamella or the ground lamella of 
the middle concha (Fig 7).  
a.Anterior Group  
These can be further divided into anterior or peri-infundibular air cells and bullar sinuses or 
the middle ethmoidal cells .Anterior cells are about 11 in number and drain into either the 
ethmoidal infundibulum or the frontonasal duct by one or more orifices while the middle 
group, which are about 3 in number, drain on or above the bulla into the middle meatus. The 
most anterior group, the agger nasi cells, are related medially to the lacrimal sac and duct. 
Larger anterior and middle cells, Haller's cells, may develop medially beneath the orbital 
floor (Fig.10). The most anterior supraorbital ethmoidal sinus cells may encroach on the 
frontal sinus.  
b. Posterior group  
These are about 7 in number drain usually by a single orifice into the superior meatus but can 
also drain into the supreme meatus or into the sphenoid sinus. As they are separated from the 
anterior group by the basal lamella, each group can get infected independent of the other in 
patients with sinusitis.  
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The Maxillary Sinus: 
The maxillary sinus (antrum of Highmore) is the largest of the paranasal sinuses and is 
pyramidal in shape (Fig.8). The base forms much of the lateral wall of the nasal cavity. The 
floor often lies below the nasal floor and is formed by the alveolar process and part of the 
palatine process of the maxilla. It is related to the roots of the teeth, especially the second 
premolar and first molar. The roof of the sinus forms the major part of the floor of the orbit 
and contains the infraorbital canal which may exhibit dehiscences. The lateral truncated apex 
of the pyramid extends into the zygomatic process of the maxilla and may reach the 
zygomatic bone, forming the zygomatic recess.  
 
The facial surface of the maxilla forms its anterior wall and the infratemporal surface of the 
maxilla forms its posterior wall. The medial wall is deficient posterosuperiorly at the 
maxillary hiatus, which is a large opening partially closed in an articulated skull by portions 
of the perpendicular plate of the palatine bone, the uncinate process of the ethmoid bone, the 
inferior nasal concha, the lacrimal bone and the overlying nasal mucosa. The ostium usually 
opens into the inferior part of the ethmoidal infundibulum and thence into the middle meatus, 
via the hiatus semilunaris( Fig 6). It is usually found lateral to the anteroinferior part of the 
uncinate process. Posterior fontanelle lies posterior to the uncinate, inferoposterior to the 
hiatus, and frequently has an accessory ostium. All the openings are nearer the roof than the 
floor of the sinus that the natural drainage of the sinus is very much dependent on the ciliary 
action. 
 
 
 
 
21 
 
Sphenoid Sinus 
The sphenoid sinuses are two large irregular cavities within the body of the sphenoid and 
therefore lie posterior to the upper part of the nasal cavity (Fig 6). At birth the sinuses are 
minute cavities and develop to adult dimensions of vertical height 2 cm; transverse breadth 
1.8 cm; anteroposterior depth 2.1 cm by puberty. In 75% of cases the median septum is 
deviated, dividing the sinuses unequally and each sinus opens into the corresponding 
sphenoethmoidal recess via an aperture high on the anterior wall of the sinus. Pneumatisation 
of ethmoids on to the sphenoid bone can give rise to Onodi cell, which is situated postero 
lateral to the sphenoid sinus (Fig.9). The internal carotid artery, the pterygoid canal, the 
maxillary branch of the trigeminal and the optic nerve lie in close relation with the sinus and 
can project into the lumen of the sinus. 
 
Nasal Mucosa (5,6) 
The lining of the anterior nasal cavity and the vestibule is by keratinised stratified squamous 
epithelium. Further posteriorly in the region of limen nasi it changes into non-stratified 
squamous epithelium and then to respiratory epithelium. Respiratory epithelium lines the rest 
of the nasal cavity and the paranasal sinuses, except in the region of olfactory cleft where the 
lining is by the olfactory epithelium. 
The respiratory epithelium has pseudo-stratified ciliated columnar cells with numerous 
seromucinous glands in the lamina propria. The mucosa is thin in the sinuses and in the meati 
while it is thick and vascular over the conchae. The secretions make the surface sticky and 
trap the particles in the respired air. The secretions of the nasal mucosa contain lysozyme, 
beta densin, lactoferrin and immunoglobulin A.  
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Nerve supply  
The nasal cavity and the paranasal sinuses are innervated by branches of olfactory nerve, 
trigeminal nerve and facial nerve. The olfactory nerve supplies the olfactory receptors while 
branches of the trigeminal nerve (ophthalmic branch V1 and maxillary branch V2) carry 
general sensation. Secretomotor fibres are supplied from the facial nerve through the 
pterygoplalatine ganglion while sympathetic supply is from the superior cervical sympathetic 
ganglion through the greater pertrosal nerve. Post ganglionic fibres are distributed via the 
branches of the maxillary nerve. 
 
Blood supply: 
The nasal cavity has rich blood supply. 
The arterial supply of the nose arises from the external as well as internal carotid arteries. The 
external carotid artery branches include the sphenopalatine, greater palatine, superior labial, 
and lateral nasal arteries while the internal carotid branches are the anterior and posterior 
ethmoidal arteries. 
The sphenopalatine artery is the terminal branch of the maxillary artery. It passes into the 
nasal cavity through the sphenoplatine foramen to divide into the posterior septal branches 
and posterior lateral nasal branches, supplying the septum and the lateral wall of the nasal 
cavity posteriorly. 
The greater palatine artery is also a branch of the maxillary artery, enters the floor of the nose 
through the incisive canal to supply the anterior part of the septum and the floor of the nasal 
cavity. 
The superior labial and lateral nasal arteries are branches of the facial artery. Both the 
anterior and posterior ethmoidal arteries are branches of the ophthalmic artery which inturn 
arises from the internal carotid artery. Both these vessels pass from the orbit into the nasal 
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cavity through the bony canals in between the ethmoidal labyrinth and the frontal bone to 
supply the adjacent paranasal sinuses and areas of the nasal cavity. The anterior ethmoidal 
artery is of particular importance in functional endoscopic sinus surgery as injury to this 
vessel can result in retraction of the vessel into the orbit and resultant orbital haematoma. 
Veins draining the nose follow the arteries and drain into the maxillary vein, facial vein and 
via ophthalmic vein into the cavernous sinus. Lymphatic drainage from the anterior region of 
the nasal cavity is into the submandibular nodes while the posterior part of the nasal cavity as 
well as the paranasal sinuses drains into the upper deep cervical nodes either directly or via 
the retropharyngeal nodes. Some drainage from the posterior nasal floor goes to the parotid 
nodes also. 
 
 
The Nasal Cycle (8) 
The nasal cycle is a well recognised physiological phenomenon characterised by rhythmic 
alternating side to side fluctuation in nasal blood flow, resulting in phases of congestion and 
decongestion of the nasal mucosa. It is regulated by the autonomic nervous system and take 
about 40 minutes to several hours to complete one cycle. The sympathetic response causes 
vasoconstriction resulting in reduction in nasal airway resistance as well as a reduction in 
venous outflow from the sphenopalatine vein while the parasympathetic stimulation causes 
vasodilatation. The nasal cycle is believed to regulate the nasal secretions, the turbulence of 
the airflow as well as the mucociliary clearance, congested phase having more rapid 
clearance (9). 
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The Mucociliary Pathway:(7) 
The mucous film in the nose and paranasal sinuses is continuosly moved into the oropharynx 
by the mucociliary escalator mechanism at the rate of 6mm per minute. The ciliary beat in the 
sinuses are towards its natural ostium (Fig.11) with a frequency of about 8 to 20 beats per 
second. Any obstruction at the sinus ostium causes retention of secretions, secondary 
infection and inflammation leading to further ciliary dysfunction and the vicious cycle sets in 
leading to chronic rhino sinusitis. 
Drainage and ventilation of the sinuses is very important to maintain the normal physiology 
of the paranasal sinuses. Normal drainage of the sinuses is a complex function of both the 
secretion and the transport mechanism. It further depends on the amount of mucus produced, 
its composition, the effectiveness of the ciliary beat, mucosal resorption and the condition of 
the ostia through which it drains. 
In health, there is a mucosal blanket which covers the nasal mucosa which has two layers – 
the inner serous layer called the sol phase and an outer more viscous layer called the gel 
phase. A proper balance is maintained between the gel phase and the sol phase at a pH
 
of 7.5 
to 7.6.The gel phase is transported over the sol phase as a mucosal carpet. Normally the 
secretions cover the mucosa of the sinuses homogenously, except at the ostia where the 
viscous layer appears to be thicker. 
Movements of the nasal mucosa especially those of the fontanelles, the negative suction 
pressure created inside the sinues due to the flow of the inspired air, synchronized ciliary beat 
and the well balanced parasympathetic neuromediator secretions help in maintaining a 
smooth mucosal transport. It is not affected by the presence of small mucosal defects, bony 
crests, small mucosal lesions or by accessory ostia less than 4 mm diameter. 
Normal ventilation, humidification, metabolism, osmotic pressure, pH
 
and absence of any 
noxious stimuli are important for the optimal functioning of the mucociliary system. 
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CHRONIC RHINOSINUSITIS 
Chronic rhino sinusitis (CRS)  is a well-recognised clinical syndrome affecting patients of all 
ages and gender(1). It is a major health problem with significant impact on the quality of life, 
productivity and finances(3). There is a wide geographical variation in the prevalence of 
chronic rhino sinusitis ranging from 1.01% to 16% (2,4). 
As per the European Position Paper on Rhinosinusitis and Nasal Polyps 2012 guidelines (5), 
chronic rhino sinusitis is characterized  by inflammation of the mucous membranes of the 
nasal cavity and the paranasal sinuses, with typical symptoms that persist for more than 12 
weeks, and objective criteria using nasal endoscopic findings with or without CT scan 
findings.  
  
The diagnostic criteria for CRS  in adults as per EPOS 2012 guidelines (5) can be 
summarized in table no. 1 
Table.1 The EPOS 2012 guidelines for diagnosis of adult chronic rhino sinusitis summarized: 
More than or 
atleast 2 symptoms 
of 
With  / without With Either 
Endoscopic findings 
of 
Or 
CT scan findings of 
Nasal blockage Facial pain or 
pressure 
Nasal polyps Mucosal changes 
within the OMC 
Obstruction Reduction / loss of 
smell 
+/-  mucopurulent 
discharge in middle 
meatus 
+/-  mucosal changes 
in the sinuses 
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Congestion  +/- mucosal 
obstruction or edema 
in middle meatus 
 
Anterior or posterior 
nasal discharge 
   
 
Chronic rhino sinusitis(CRS) can be broadly classified as chronic rhino-sinusitis with nasal 
polyps (CRSwNP) and without nasal polyps (CRSsNP) based on the endoscopic findings. 
Sinusitis without polyposis has more fibrosis, high levels of TGF and increased Treg activity 
(11,12).  
The incidence of both subtypes of sinusitis is believed to increase with age, with a peak 
incidence in the age group of 50-59 years (13). The average age of onset of nasal polyps is 
around 42 years (14,15), and is more common in men than women (16). 
Aetiopathogenesis of sinusitis: 
The fundamental principle in the development of CRSsNP is the obstruction in the drainage 
pathways of the sinuses resulting in stasis of secretions while in CRSwNP there is diffuse 
mucosal response (17).  
The osteomeatal complex obstruction may be anatomical, physiological or a combination of 
both. It leads to cessation of normal sinus drainage patterns and stagnation of secretions. The 
gas exchange becomes impaired, favouring the growth of anaerobic bacteria and promoting 
infection. Inflammation further worsens the ciliary dysfunction, leading to further stasis of 
secretions and thickening of the mucous membrane in the sinuses. This leads to repeated or 
chronic sino-nasal infection.  
The aetio-pathogenesis of chronic rhino sinusitis is believed to be multifactorial (18). 
Etiological factors described include ciliary dysfunction, allergy, asthma, aspirin sensitivity, 
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immune status, genetic factors, iatrogenic factors, gastric reflux, local host factors, pregnancy 
and endocrine state, commensal flora, biofilms, pathogens and its characteristics and 
environmental factors (19). 
There are several hypothesis proposed regarding the pathogenesis of sinusitis. The first 
hypothesis proposed was ‘fungal hypothesis’ which explained sinusitis as due to excessive 
host response to Alternaria fungi (20). Other proposed hypotheses include the immune barrier 
hypothesis, defects in the eicosanoid pathway, the staphylococcal super antigen hypothesis 
and genetic model in cystic fibrosis (11,21,22,24). Whatever be the mechanism, there is 
dysregulation of the local innate host defense mechanism leading to microbial colonization 
and site specific immunoglobulin production. Inappropriate or excessive immune response 
results in persistent mucosal inflammation, cellular influx, radiographic changes and clinical 
disease. 
Diagnosis of chronic rhino sinusitis 
Diagnosis of CRS in a primary care set up is mostly based on the symptomatology while a 
specialist relies on nasal endoscopy and radiological findings in addition. Additional tests like 
blood investigations and bacteriological cultures might help in defining the 
aetiopathogenesis. 
The symptoms in sinusitis with or without polyps are mostly the same, but the pattern and 
intensity may vary. The most common symptom reported is nasal obstruction (84-92%) 
followed by post nasal drip (82- 87%) (25,26). 
Assessment of symptoms and symptom severity: 
The overall severity of symptoms in CRS can be recorded either by using visual analogue 
scale (VAS) or by using a validated symptom based health related quality of life (HRQOL) 
questionnaire. The visual analogue score is based on the severity of symptoms and is graded 
as mild, moderate, and severe. While the symptoms of sinusitis are well known, the disease 
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also affects several other aspects of the patient’s life which are often not documented by the 
physician. Several studies have noted that the overall well –being of a patient should look at 
the quality of life changes that the disease produces. Chronic diseases often affect the social 
and emotional aspects of a patient’s life. It is important, therefore, to assess these domains as 
well when reporting on the degree of the problem in a disease state as well as the response to 
treatment. The tools used to assess QOL in sinusitis should be validated and designed for a 
particular age group and to assess specific domains. There are several validated tools 
available currently for evaluation of chronic rhino sinusitis in the adult population. One of the 
most commonly used QOL instrument is the Sino Nasal Outcome Test (SNOT). Based on the 
number of questions asked, this questionnaire is available in 3 versions (SNOT 22,SNOT 20 
and SNOT 16).  Other QOL instruments include Rhinosinusitis Outcome Measure (RSOM-
31), Rhinosinusitis Disability Index (RSDI), Rhino QOL, Chronic Sinusitis Survey (CSS) 
and Sino-Nasal Assessment Questionnaire (SNAQ-11)(18, 27-32).The various features and 
domains covered by the various QOL instruments are summarized in  Table.2. 
Table.2 QOL instruments used in adult chronic rhino sinusitis: a summary (EPOS 2012) 
QOL instrument Number of 
Questions 
Domains 
covered 
Completion 
time 
Translations 
RSOM-31 31 7 20min Nil 
 
SNOT 16 16 2 5 min French 
 
SNOT 20 20 3 5-10 min Japanese,Chinese, 
Portuguese 
SNOT 22 22 3 5-10 min Danish, Czech, 
Swedish, Chinese 
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Rhino QOL 17 3 5-10 min French 
 
CSS 6 2 5 min Norwegian 
Chinese 
RSDI 20 1 5 min Turkish 
 
SNAQ-11 11 1 5 min Nil 
 
 
 
 
Sino nasal outcome test (SNOT22) is a validated, visual analogue scoring based 
questionnaire which was initially based on 16 criteria (SNOT 16) and later modified to SNOT 
20 and, further, to SNOT 22 by adding two more items on smell disturbances and nasal 
obstruction(32). The SNOT 22 questionnaire (Table.3) covers various domains like the nasal 
symptoms, non- nasal symptoms (facial and ear symptoms), psychosocial aspects and sleep 
functions. The questionnaire has 22 symptoms, assessed in the order of increasing severity, 
each symptom graded 1 to 5, with a maximum score of 110.In a study done by Hopkins et al, 
it was established that a SNOT22 score of more than 7 may be an indication of sinusitis (23). 
This QOL instrument is a cross culturally adapted tool, with versions in other languages 
(33,34,35) and had been applied to study various surgeries on nose like septoplasty (36)  and 
endoscopic surgery for sinusitis (37).  
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Table 3: SNOT 22 questionnaire 
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Nasal Endoscopy 
With the advent of endoscopes, nasal endoscopy has become a part of the routine 
examination of the nasal cavity. It serves as an objective, diagnostic tool in the evaluation of 
nasal mucosa, sinonasal anatomy and nasal pathology (Fig.12.a). Finding of mucopus in the 
middle meatus is diagnostic of sinusitis (Fig 12.b). The presence of nasal polyps and its 
characteristics can also be identified on endoscopy (Fig 12.c). 
a) Procedure of diagnostic nasal endoscopy: (7) 
After explaining the procedure and obtaining consent, the nasal mucosa is sprayed with a 
mixture of topical anesthetic and mild vasoconstrictor in equal parts. Alternatively, one can 
use a nasal pack with 4% lignocaine and xylometazoline which is left in the nose for about 2 
to 5 minutes. The patient is made to lie supine with the head turned to the right, facing the 
examiner. A 4 mm 30
0 
endoscope is used to examine the nasal cavity. The patient may also 
sit facing the examiner who is also seated.  Classically, 3 “passes” are described. In the first 
pass, the endoscope is advanced along the floor inspecting the nasal vestibule, the inferior 
nasal meatus and the nasal cavity. In the second pass the scope is passed medial to the middle 
turbinate to examine the spheno-ethmoidal recess and the superior meatus. In the third pass, 
the scope is withdrawn and reintroduced into the middle meatus examining the structures 
within. The endoscope is held between the thumb and forefinger on the left hand, which rests 
lightly on the cheek and the nasal bridge. Care has to be taken not to injure the mucosa at any 
point of the examination. 
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b) Endoscopic scoring system 
Many endoscopic scoring systems have been developed to record the endoscopic findings in 
a universally accepted way. The Lund –Kennedy endoscopic scoring system (LKES), the 
Kupferberg scoring system and the perioperative sinus endoscopic score (POSE) are the three 
well accepted scoring systems. 
 The Lund-Kennedy endoscopic scoring system (Table 4) is a widely accepted endoscopic 
scoring system which quantifies the pathologic states of the nose and paranasal sinuses. The 
scoring system is focused on the presence of polyps, discharge, edema, scarring, or adhesions 
and crusting. The scores range from 0 to 20 (38). Polyps are graded as absent (0), present in 
the middle meatus (1), or present beyond the middle meatus (2). Discharge is graded as not 
present (0), thin (1), or thick and purulent (2).Edema, Scarring, adhesions and crusting are 
used in postoperative assessment, each graded as absent (0), mild (1), or severe (2).    
Table 4: Lund Kennedy Endoscopic Scoring summarized 
Right/Left Score 0 Score 1 Score 2 
Polyps absent In the middle meatus Beyond the MM 
Discharge absent Thin Thick / purulent 
Edema absent mild Blocking the OMC 
Scarring absent mild severe 
Crusting absent mild severe 
Synechiae absent mild severe 
 
Endoscopic staging is performed bilaterally and typically takes place during the initial 
evaluation, preoperatively, and postoperatively at regular intervals. Kuhn emphasize that 
adding nasal endoscopy to the care of patients with CRS results in improved diagnostic 
accuracy (40). In combination with established symptom criteria, endoscopic findings 
33 
 
improve the specificity, positive predictive value and negative predictive value of assessment 
for chronic rhino sinusitis (41). This development suggests that the use of diagnostic 
endoscopy may help decrease the need for computed tomography (CT) and reduce costs and 
radiation exposure. 
The Kupferberg postoperative scoring system described for allergic fungal rhino sinusitis 
(AFRS) has 4 stages (0-3) based on the `global` appearance of one side of the nose and is 
summarized in Table 5. 
Table 5: Kupferberg postoperative endoscopic staging for allergic fungal sinusitis 
      Stage                 Endoscopic finding 
     Stage 0 No  mucosal   edema or allergic mucin                                                        
    Stage 1 Mucosal edema with or without allergic mucin 
    Stage 2 Polypoid edema with or without allergic mucin 
    Stage 3 Sinus polyps with fungal debris or allergic mucin 
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Imaging in sinusitis  
The plain x-ray of the sinuses has limited usefulness for the diagnosis of chronic rhino 
sinusitis as compared with the CT scan. The negative predictive value of CT scan is high in 
sinusitis. However, in the absence of symptoms, diagnosis of CRS based on radiology alone 
is inappropriate, as incidental abnormalities are seen in up to a fifth of the normal population 
(43). The Lund Mackay system is a widely accepted, validated staging system based on CT 
scan findings (Fig 13). The maximum score is 12 per side and is summarized in table no: 6. 
Most of the studies have shown the mean Lund Mackay score in patients with CRSwNP  is 
significantly higher than in those with CRSsNP (39) 
Table: 6 The Lund Mackay Staging system for sinusitis based on CT scan findings 
Sinus Score = 0 Score= 1 Score=2 
Maxillary sinus Normal Partial opacification Total opacification 
Anterior Ethmoids Normal Partial opacification Total opacification 
Posterior Ethmoids Normal Partial opacification Total opacification 
Sphenoid sinus Normal Partial opacification Total opacification 
Frontal sinus Normal Partial opacification Total opacification 
Osteo-meatal complex Not occluded   _ Occluded 
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Management of Chronic Rhino sinusitis 
The management of CRS varies with the underlying etiology as well as with the presence of 
sinonasal polyposis. There are few controlled studies that have looked at specific modalities 
of management.   
Severity of CRS 
The EPOS 2012 guidelines have graded the severity of CRS based on visual analogue scale 
scores. A VAS score of 0-3 is considered as mild disease, while 3 – 7 is moderate and 7-10 is 
a severe disease. The following are the guidelines for treatment of CRS as per EPOS 12 
guidelines. 
a) CRSsNP. In CRS without polyposis, mild disease is treated with topical cortical 
steroids and nasal lavage. If the treatment fails at 3 months, the disease is treated as 
moderate / severe disease. Moderate / severe disease is treated with topical 
steroids / nasal lavage / and long term (4 weeks) of macrolide therapy or as per 
culture and sensitivity. 
Medical management of chronic sinusitis without polyposis in our practice does not 
follow all of the EPOS guidelines. Patients are administered at least 2 weeks of 
antibiotics, decongestants and saline drops and reviewed. If they have undergone at 
least 3 courses of antibiotic therapy and have significant symptoms with persistent 
endoscopic and radiological findings, they are recommended to undergo functional 
endoscopic sinus surgery. 
 
b) In CRSwNP, mild and moderate disease are managed initially with topical 
corticosteroid sprays and reassessed at 3 months. If there is no improvement of 
symptoms, a short course of oral steroids can be added for 1 month. If the patient 
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continues to be symptomatic a surgical intervention can be considered. Severe 
disease warrants use of oral as well as topical corticosteroid for 1 month and if no 
improvement is noted, surgical intervention has to be considered. The medical 
management of CRS with polyposis is similar in our practice. However, we prefer to 
operate on these patients earlier rather than after a month long course of oral 
steroid in order to avoid missing coincident pathology (like fungal sinusitis or 
inverting papilloma) as well as to reduce costs for the patient. 
 
 
Surgery in chronic rhino sinusitis 
Historically established surgical techniques for the management of chronic rhino sinusitis 
include antral lavage, Caldwell Luc procedure, intranasal polypectomy, external or 
transantral ethmoidectomy or spheno-ethmoidectomy and external frontal sinus surgery 
depending on the sinuses involved. However, with the advancement of endoscopic surgical 
procedures over the past two decades, the surgical management of sinusitis has completely 
changed.  
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FUNCTIONAL ENDOSCOPIC SINUS SURGERY  
Functional endoscopic sinus surgery (FESS) is a minimally invasive surgical technique in 
which the sinus ostia are opened under direct visualization, preserving as much as nasal 
mucosa as possible, with an aim to restore sinus ventilation and normal function. 
a. Techniques of FESS 
FESS can be performed either under general anesthesia or under local anesthesia, depending 
on the extent of the disease and the patient factors. The patient is positioned supine with the 
head turned to the right and a 15 degree tilt to the table in reverse Trendelenberg position. 
The surgeon stands on the right side of the patient facing the head, with the monitor in front. 
The endoscope is held in the left hand while the instruments are held on the right. 
Traditionally, two techniques had been described in FESS – The Messerklinger technique and 
The Wigand technique. The Messerklinger technique addresses the sinuses from anterior to 
posterior while the Wigand technique is a posterior to anterior approach. However, it is 
believed that the complications and outcome depend more on the patient factors than the 
surgical technique. The National comparative audit reports perioperative bleeding as the most 
common complication. This study has reported major complications as 0.4% and minor 
complication as 6.6% (53). 
Modification to the surgical instruments, better optics, advances in imaging and newer 
armamentarium like microdebrider have all added to better outcomes in endoscopic surgery 
in experienced hands.  
 
 
b. Postoperative management following FESS 
Following the surgery, the nasal cavity is packed either with BIPP or dehydrated gelatin 
sponge. The packing is removed on the following day and the patient is taught to periodically 
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wash and flush the nasal cavity with saline. Weekly endoscopic guided cleaning is performed 
in the outpatient clinics, to remove the debris and clean the cavities, till the surgeon is 
satisfied with the healing (Fig.14 a,b) 
The patients are advised further follow up and medications depending on the etiology and 
extent of the disease. 
c. Outcomes following FESS 
FESS has now become a well established surgical modality in the treatment of sinusitis 
refractory to medical treatment. However, there is a conspicuous lack of good surgical 
evidence on the efficacy of this intervention comparing it to the various other modalities as it 
is difficult to standardize the surgery and to randomize and conduct blinded studies. 
In the literature, there are several systematic reviews which have looked at the functional 
outcome of sinus surgery in children as well as adults (44, 45). However, most of these are of 
low evidence levels due to the difficulty in obtaining homogenous sample groups and the 
issues in randomization and standardization of the techniques.  
Terris and Davidson conducted a meta-analysis, assessing the outcome of endoscopic sinus 
surgery, with a total of 1,713 patients, and found some subjective improvement in the 
symptoms in 91% of patients. They reported bleeding as the most common complication 
(1.5%) and the rate of revision surgery was 12%(57). In their prospective study on 
endoscopic sinus surgery in patients with chronic sinusitis with and without polyposis, 
Timothy et al assessed the outcome of endoscopic sinus surgery both subjectively and 
objectively by using the QOL instruments RSDI and CSS along with CT scan scoring and 
endoscopic scoring of the disease. The mean follow up was 1.4 years and they found 
significant improvement in QOL scores as well as in the endoscopic scores, following FESS, 
irrespective of the presence of polyps. Even patients who underwent revision FESS had 
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significant improvement in QOL scores though the endoscopic scores were comparatively 
worse(56).  
Another prospective study by Tyson et al reported patients with polyps as having poorer 
outcome following FESS in comparison with those without polyps. They had included 201 
patients in their study, of which 78 had polyps and 123 had no polyps. Pre operative and post 
operative QOL scores were obtained using SNOT 20 questionnaire and patients were 
followed up for a minimum of 1 year. The mean preoperative score in those with polyps was 
32.2 with an improvement to 9.1 at 12 months follow up. The mean SNOT 20 score in those 
without polyps was 26.5 preoperatively which improved to 5 at 12 months postoperatively. 
Nine patients had required revision surgery of which 8 had polyps(54). In the National 
comparative audit of surgery using SNOT 22 score, on patients undergoing surgery for 
chronic sinusitis, Hopkins et al found that sinonasal surgery is safe and effective in reducing 
nasal symptoms over a 5 year period (37). 
 
Post operatively, patients reported a 14 point 
improvement over the base line score. Polyp patients reported a better SNOT 22 score at 5 
years (mean 26.2,SD 21.6)  than with CRS alone (mean :33.3 SD 23.7). The rate of revision 
surgery was 3.7% at the end of 1 year, and was higher in the group of sinusitis with polyps as 
compared to without polyps. 
In a prospective study with 3 year follow up, Giger et al reported subjective satisfaction in 
92% of the patients who underwent FESS in sinusitis without polyposis(58). The endoscopic 
scoring also had correlated well with the subjective outcome scores. 
In another study by Khalid et al using SF-36 in post FESS patients with a follow up of 3 
years, it was found that FESS resulted in significant improvement in quality of life(49). 
Mace et al correlated endoscopic findings with the Rhino sinusitis Disability Index in patients 
with sinusitis and concluded that there was a statistically significant improvement in health 
related QOL as well as endoscopy scores after endoscopic sinus surgery in sinusitis. Also, the 
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changes in QOL were reflected on endoscopy (42).In their prospective study of patients 
undergoing FESS for chronic sinusitis, Chopra et al found that 82 % of the patients improved 
postoperatively (47).  
The Cochrane review 2006, later updated in 2009 assesses FESS as a safe surgical procedure 
but could not demonstrate any additional benefit to that obtained by medical treatment in 
chronic rhino sinusitis (46).  
As there is evidence that chronic rhinosinusitis with and without polyps are distinct 
subgroups of inflammatory disease of the upper airway, many studies had been conducted 
separately for these two groups. A systematic review by Dalziel et al compared outcome of 
FESS for nasal polyps with other procedures like Caldwell-Luc, intranasal ethmoidectomy 
and polypectomy(51). They reported a symptomatic improvement of 78-88 % following 
FESS  as against 43-84%  in other procedures. The recurrence rate was 8% in FESS and 28% 
in endoscopic ethmoidectomy, 14% for Caldwell-Luc and 35% for polypectomy. The rate of 
complication was 1.4% for FESS and 0.8% for conventional procedures(51). ). In their 
systematic review comparing FESS to conventional techniques, Lund et al reported success 
rates ranging from 70% to 90%, while the complication rates were below 1%. The rate of 
revision surgery was 7 to 10 %(45) 
The effects of primary and revision FESS were compared by Lee et al(52).  The authors 
found significant improvement in SNOT 20 scores and endoscopic score in both the groups at 
the end of 12 months follow up. There was, however, no statistically significant difference. 
Despite the widespread use of FESS techniques in ENT practice, we did not encounter many 
studies among Indian patients where a QOL instrument was used to determine benefit from 
sinus surgery. By using both the SNOT 22 questionnaire and the Lund Kennedy endoscopic 
scoring system, we have subjectively and objectively assessed the patients with CRS, to note 
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if the surgery was beneficial or not and whether symptom relief was greater for some 
symptoms compared to the others. 
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                            Materials and Methods 
a) Study design  
This prospective observational study was conducted in the Department of ENT at Christian 
Medical College Vellore, between July 2011 and August 2012.  
 b) Subjects 
All patients aged 18 years and above who were diagnosed with chronic sinusitis with or 
without sinonasal polyposis, scheduled to undergo functional endoscopic sinus surgery, were 
included in the study. 
c) Inclusion criteria 
All patients who were 18 and above and had met the criteria of chronic sinusitis as per EP3OS 2007 
guidelines. 
d) Exclusion criteria 
The exclusion criteria were as follows: 
Age below 18 years  
Septal deviation without sinusitis  
Invasive fungal disease 
Complications of sinusitis 
 Associated malignancy  
Specific infections like TB and rhinosporodiosis  
e) Informed consent  
For all patients an informed consent was taken before including them in the study, after 
providing relevant details about the study in their language. The consent form and the patient 
information sheet are attached as Appendix A. 
f) Sample size  
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Sample size for this study was calculated using the following formula 
2
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Where,  
n = sample size 
p1 = mean SNOT 22 score preoperatively 
p2 = mean SNOT 22 score postoperatively 
P = (p1 +p2) / 2 
Q = 1 – P
 
 Alfa = 5% 
 Beta = 80% 
Using the data from The National Comparative Audit of Surgery for Nasal Polyposis and Chronic 
Rhinosinusitis (Ref), the average preoperative SNOT 22 score was taken as 41.5(SD 20.2) and post 
operative score was taken as 25.3 (SD 20.8) at 3 months post op and 28.5 (SD 22.7) at 1 year postop.  
 Based on this, the sample size needed was at least 22 at the end of 1 year. Since we estimated that we 
may have only 20% follow up at the end of 1 st year, we calculated a sample size of 90, considering a 
9 point improvement in SNOT 22 score postoperatively.  
g) Method 
After obtaining consent and a brief history, patients were asked to fill the SNOT 22 
questionnaire themselves. Assistance was provided on demand. 
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Preoperatively rigid nasal endoscopy using a 4mm rigid scope was performed to assess the 
nasal cavity and Lund Kennedy scoring done.  
Post operatively during the follow up visit at 3- 6 months,  they were approached for filling 
the SNOT 22 questionnaire in the same manner along with a repeat office endoscopy. 
Postoperative scoring was done with the Lund Kennedy scoring system. 
h) Statistical analysis  
The patient details were entered in the MS excel sheet and analyzed. Descriptive data was 
analysed using frequency distribution for all the variables assessed. Descriptive data was 
analysed using frequency distribution. The data was analyzed in separate groups of chronic 
sinusitis with nasal polyps and chronic sinusitis without polyposis using SPSS tool. Pearson 
Chi-square test and Fisher’s exact test was used for categorical data to check the association 
between preop and post operative scores.  
The change in SNOT 22 score and comparison with the endoscopic scoring was done using 
independent and paired t test.  
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                                         RESULTS 
A total of 90 patients with chronic sinusitis were included in the study. Sinonasal polyposis 
was present in 69 patients (76.7%) and absent in 21 patients (23.3%). 
  
 
 
Fig.15 Patient distribution in two groups of chronic rhino sinusitis 
 
 
 
 
 
 
 
 
 
76.7 %
23.3%
Patient distribution in the two groups (n=90)
Cases with polyps : 69 patients
Cases without polyps: 21 patients
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a) Age distribution 
The ages of the patients ranged from 18 to 70 years with a mean of 41.17 (S.D = 14.8) years. 
The age distribution of the study population is summarised in the following table: 
Table 7: Age distribution of patients included in the study 
Age group      Number of patients (%) 
< 20   years              11(12.2%) 
20-30 years              12 (13.3%) 
30-40 years              20(22.2%) 
40-50 years              21(23.3%) 
50-60   years              23(25.5%) 
 60     years              3    (3.3%) 
Total              90 (100 %) 
 
In the group of patients with polyps, the age ranged between 18- 70 years (mean 39.58 years) 
while in those without polyps the age range was between 25 to 70 years (mean of 46.38 
years). This is well illustrated in Table 8 and Fig. 16. 
 
 
 
 
 
 
 
 
 
47 
 
Table 8: Age distribution of patients in patients with polyps and without polyps 
Age (years) Number of patients with 
polyps (%) 
Number of patients without 
polyps(%) 
< 20 11 (15.9%) 0 
20-30 9   (13%) 3(14%) 
30-40 15(21.7%) 5(24%) 
40-50 15(21.7%) 6(28.5%) 
50-60 18(26%) 5(24%) 
>60 1(1.7% 2 (9.5%) 
Total patients 69 21 
 
 
 
It was observed from the data that patients with polyps were relatively younger than those 
without polyps. However, it was not statistically significant (p value .357). The prevalence of 
sinonasal polyps was greatest in the 5
th
 decade. This is also illustrated in the figure below. 
 
 
 
 
 
 
 
 
 
 Fig 16 Comparative age distribution in both the group
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 b) Sex distribution (Fig. 17)
Out of 90 patients, 57 (63.3%) were male and 33 (36.7%) were female.
Fig 17 Sex distribution in both the groups of patients 
In the group with polyps, there were 46 males (66.7 %) and 23 females (33.3%) while in the 
group without polyps, there were 11 males (52.4%) and 10 females (47.6%).Figure 17 
illustrates the difference in sex distribution between the two groups. It is evi
data that all the groups had more male than female patients.
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c) Duration of complaints  
The duration of complaints ranged from 2 weeks to 120 weeks with a mean of 34 weeks 
(S.D. =29.46). In the group with polyps, the average duration of the complaints was 
33.7weeks (2 weeks to 120 weeks); while in the group without polyps the mean was 35.9 
weeks (3 weeks to 80 weeks). 
 
 
 
d) Presence of co morbidities 
A total of 46(51%) patients had a co morbid illness while 11 of them had two co morbid 
illnesses. Hypertension (24.4%) was the most common co morbid illness. Out of 22 patients 
with hypertension, 15(68%) of them had polyps. The second commonest co morbidity was 
diabetes mellitus. The disease was present in 13 (14.4%) patients. Nine patients (10%) had 
bronchial asthma, out of which 8 of them had nasal polyps.  It is observed from the data that 
co morbidities like diabetes mellitus, bronchial asthma and hypertension are more common in 
those patients with polyps. The co morbidities and its distribution in both the groups are 
summarized in Table 9. 
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Table 9: Pattern of distribution of co morbid illnesses 
 Total number of 
patients (%) 
Number with polyps 
(%) 
Number without 
polyps (%) 
Diabetes 13(14.4) 10(14.5) 3(14.3) 
Hypertension 22(24.4) 15(21.7) 7(33.3) 
Asthma 9  (10) 8(11.6) 1(4.8) 
Immunocompromise 4  (4.4) 3(4.3) 1(4.8) 
Hypothyroid 9  (10) 5(7.2) 4(19) 
Total  57 41 16 
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The distribution of co morbidities is also illustrated in the figure below: 
Fig 18.Distribution pattern of co morbid Illnesses in patients with and without polyps 
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e) Primary versus revision surgery (Fig. 19) 
A total of 74 patients (82.2%) had FESS while 16 patients (17.8%) had revision FESS. 
Fourteen out of 16 (87.5%) patients who had revision FESS had polyposis. Clearly, patient 
with sinonasal polyposis had recurrent disease compared to those without. 
 
Fig 19: Percentage distribution of patients undergoing Primary / Revision FESS 
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f) Presence of allergy (Fig. 20) 
A total of 55 patients (61.1%) had complaints suggestive of associated allergy, like sneezing 
or urticaria. It was more so in the group with polyps (73.9%) as against 19% in the group 
without polyps. Out of the 55 patients who had allergy, 25 of them had their Ig E levels 
tested. Nineteen out of 25 patients (76%) tested for Ig E levels in serum had raised levels. 
Fig 20 Prevalence of allergic symptoms in patients with and without polyps 
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g) Use of prior antibiotics 
A total of 65 patients (72.2%) out of 90 had received at least 1 course of antibiotics prior to 
the surgery. In the group of patients without polyps, 18 of them (85.7%) had received 
antibiotics while 47 patients (68.1%) in the polyp groups received antibiotics. 
 
h) Use of steroids  
A total of 54 patients (78.3%) in the group of cases with polyps had received either nasal 
steroid spray or a short course of perioperative oral steroids or both, while only 3 patients in 
the group without polyps had received steroids. The 3 in the group without polyps had 
received oral steroid because of their allergic complaints. 
Postoperatively, 73 patients (81.1%) had received either a nasal corticosteroid spray or a 
spray combined with a short course of steroid to be continued for about 12 weeks. Only 17 
patients were taken off all the drug therapy at 2 weeks postoperatively. All patients were 
advised to return for follow up after 3 months.  
 
i) Histopathological examination 
Out of 90 patients, 86 patients had histopathological evaluation at our institution.Out of the 
86 patients,54(62.8%) were reported as chronic inflammatory polyps, while 32(37.2%) had 
feartures suggestive of allergic fungal sinusitis,as with allergic mucin or evident fungal 
hyphae. In the group of patients with polyps, 40 patients (58.8%) had histopathological 
features suggestive of chronic inflammatory polyps while 28 (41.2%) of them had features 
suggestive of allergic fungal sinusitis.In patients without polyps, 14(77.8%) of them had 
chronic inflammatory changes while 4(22.2%) of them had fungus: suggestive of a fungal 
ball. In 16 patients who underwent revision FESS, 10 patients (66.7%) had histopathological 
features of allergic fungal sinusitis while the rest had chronic inflammatory polyps.  
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j) Fungal culture results 
In 33 patients, a fungal aetiology was suspected clinically and fungal culture of the tissue was 
obtained. Only 10 out of the 33 cultures grew fungus. Seven of the cultures reported 
Asperigillus flavus, while two reported Asperigillus fumigatus and one had mixed growth of 
Asperigillus flavus and fumigatus. 
 
k) Preoperative SNOT 22 score 
All the patients enrolled in the study were asked to fill the SNOT 22 questionnaire 
preoperatively. The preoperative score varied from 7 to 70, with a mean of 29.27 (S.D.= 
13.5). Out of 90 patients, 89 of them (98.9%) had a score more than 7. In the group with 
polyps, the mean score was 30.52 (S.D = 12.9), and all patients except 1 had a score more 
than 7 (98.6%). In the group without polyps, the mean preoperative score was 25.14 (S.D.= 
14.9). All patients in the group with sinusitis without polyposis had a score more than 7 
preoperatively. It is evident from the data that if we are to consider a score more than 7 as 
indicative of having rhinosinusitis, all except one had met that criterion preoperatively. Also, 
the group with polyps was evidently more symptomatic with a higher SNOT score. 
The SNOT 22 questionnaire scoring was sub-analysed in each group, dividing the questions 
into three domains: nasal complaints, non-nasal complaints and psychosocial complaints. The 
values are summarized in the table below. 
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Table 10: Sub analysis of the preoperative SNOT 22 score 
 Complaints Range of values Mean score Standard 
deviation 
Rhinosinusitis 
with polyposis 
 Nasal 3-32 18.5 6.92 
Non-nasal 0-14 2.82 3.19 
Psychosocial 0-38 9.0 8.18 
Total score 7-70 30.52 12.9 
Rhinosinusitis 
Without polyposis 
Nasal 1-28 14.43 7.9 
Non-nasal 0-10 3.19 3.01 
Psychosocial 0-28 7.61 8.23 
Total score 9-66 25.14 14.9 
 
It is obvious from the data that patients reported more of nasal complaints as compared to the 
non-nasal and psychosocial complaints in both the groups. But statistically there was no 
difference between both the groups. 
The preoperative SNOT 22 questionnaire was also analysed aganist the various comorbid 
illnesses reported, to identify if there was any significant difference among these diseases on 
severity of symptoms. There was no statistical significance in the SNOT 22 scores between 
the groups, the inferences summarized in the following table. 
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Table 11.Preoperative SNOT 22 scoring aganist the various co morbid conditions 
 Mean score 
in affected 
cases 
Mean score in 
not affected 
cases 
‘p’ value Statistical 
significance 
Diabetes 36.29 27.63 0.176 Not significant 
Hypertension 32.42 27.71 0.368 Not significant 
Bronchial asthma 34.50 28.35 0.456 Not significant 
Immunocompromised 27.50 28.9 0.856 Not significant 
Hypothyroidism 22.20 29.58 0.260 Not significant 
 
l) Postoperative SNOT 22 score 
Out of a total of 90 patients, 50 patients came for follow up between 3 to 6 months 
postoperatively. All of them were asked to fill the SNOT 22 questionnaire again during the 
follow up visit. The postoperative SNOT score ranged between 0-44, with a mean score of 
9(S.D 9.7). Out of the 50 patients, 28 (56%) had a post operative score less than 7, while 22 
(44%) of them continued to have a higher score than 7. In the group with polyps, 37 patients 
came for follow up. The mean postoperative score was 9.11 (S.D 10.5) with 22 patients 
(59.5%) reporting a score less than 7. In the group without polyps, 13 patients came for 
follow up and reported a mean score of 8.69(S.D 7.5). Out of 13 patients, 6 of them (46.2%) 
reported a score less than 7. 
 
 
It is evident from the data that there is a significant improvement in the SNOT scores 
postoperatively. However, the majority of the patients continued to have a score higher than 
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7, which means that even after surgery they did not come to a score which was suggestive of 
a normal individual in the follow up period defined in the present study. 
Post operative SNOT score was also sub analysed in the three domains of nasal, non-nasal 
and psychosocial complaints. The results are summarised in the table below. 
 
Table 12: Sub analysis of postoperative SNOT 22 scores 
 Complaints Range of values Mean score Standard 
deviation 
Rhinosinusitis 
with polyposis 
Nasal 0-29 7.21 6.67 
Non-nasal 0-4 0.37 1.00 
Psychosocial 0-4 0.37 1.00 
Total score 0-44 9.11 10.4 
Rhinosinusitis 
Without polyposis 
Nasal 0-10 5.07 2.87 
Non-nasal 0-3 0.92 1.03 
Psychosocial 0-3 0.31 0.85 
Total score 1-28 8.69 7.52 
 
There appeared to be a significant reduction in the non-nasal and psychosocial symptoms 
postoperatively in both groups of patients (Table 12). However there was no statistically 
significant difference between both the groups, in all the three domains. 
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m) Preoperative LKES score 
All the patients included in the study had a preoperative endoscopy and Lund Kennedy 
scoring of the findings. In the group with nasal polyps the preoperative LKES average score 
was 7.7 (S.D.= 2.65).In the group without polyps, the preoperative average score was about 
6.14 with a range from 2 to 14 (S.D.= 2.97).The data suggests that the patients with polyps 
have a higher pre operative Lund Kennedy score as compared to those without polyps. 
 
n) Postoperative LKES score 
Post operatively at 3 to 6 months, in the group with polyps the mean LKE score was 1.94 
(S.D = 2.6) and in the group without polyposis the mean LKE score was 2.04 (S.D = 
2.08).Though both the groups of patient with polyps and without polyps showed 
improvement in the score, it was less pronounced in the group without polyps , as evident 
from the values. 
 
0) Preoperative Lund Mackay score 
The Lund Mackay scoring was done on the CT scan images of 75 patients preoperatively. The 
mean score was 13.44(S.D =7.46).In the group with polyps, there were 57 patients. The mean score in this 
group was 15 and all of them had atleast one side osteomeatal complex occluded. In the 
group without polyps 18 scans were analysed and the mean score was 8.5 with  72.3%  of  
patients with at least one osteomeatal complex occluded. Overall, 93.3% of patients (70/75) 
had at least one osteomeatal complex blocked. 
 
 
 
 
 p) Comparison of preoperative
The preoperative and post operative SNOT 22 questionnaire scores of the 50 patients who 
came for the follow up were compared and analyzed separately. Also, the scores were sub 
analysed in two groups of those with polyps and those 
in the group with polyps and 13 patients in the group without polyps.
The mean total SNOT 22 score preoperatively was 28.84(S.D.= 15.6), while the mean 
postoperative score was 9.0 (S.D.= 9.7).Out of the 50 patients wi
them(98%) had a preoperative score more than 7 and 28 of them improved after the surgery 
to have a score less than 7.The mean improvement in the total score was 19.8 (p=0.00), 
which was statistically significant. The preoperative and po
comparison is illustrated in the figure (Fig. 21) below.
Fig 21 Comparison of SNOT 22 score preoperatively and post operatively
In the group of patients with polyps, a total of 37 patients returned for follow up, and the 
mean preoperative score was 29.95(S.D.= 15.47) and mean post operative score was 
9.11(S.D = 10.45). In the group of patients without polyps, the mean preoperative 
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 and postoperative SNOT 22 scores
without polyps. There were 37 patients 
 
th follow up, 49 of 
st operative SNOT 22 score 
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score was 
 25.69(S.D = 16.23) and mean postoperative score was   8.69(S.D = 7.52). Out of 37 patients  
in the group with polyps, 31 patients (83.8%) improved at least by 9 points postoperatively, 
while 84% (11/13 patients) improved  by at least 9 points in 
mean improvement of total score was 20.8 in the group with polyps (p=0.00) and 17.0 in the 
group without polyposis (p=0.01). Hence, there was statistically significant improvement in 
SNOT 22 score in both the groups postoperat
comparable in both the groups with no statistical difference (p=.338). The comparison of 
scores in both the groups is illustrated in the figure (Fig. 22) and the calculations summarized 
in the table given below. 
Fig 22 Comparison of SNOT 22 score in both the groups pre operatively and post operatively
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Table 13: Comparison of SNOT 22 score in both the groups pre operatively and post 
operatively 
 Mean preop 
SNOT 22 score 
Mean post op 
SNOT22 score 
Mean 
improvement 
P value 
Group with 
polyps (n=37) 
29.95 9.11 19.8 0.00 
Group without 
polyps (n=13) 
25.69 8.69 20.8 0.00 
Total score 
(n=50) 
28.84 9.0 17.0 0.01 
 
Also a comparative analysis of the SNOT 22 scores were done between the groups of  
primary FESS and revision FESS. There were 40 patients in the group of primary FESS and 
10 patients in the group of revision FESS. All the patients except one (39/40) in the group of 
primary surgery had a preoperative score more than 7, with a mean score of 25.62(S.D= 
14.2).Post operatively, 32 patients (80%)  improved at least by 9 points and the mean post 
operative score was 8.78(S.D 10.47).The mean improvement in the score was 16.8 
points(p=0.00),which was statistically significant. 
In the group of revision FESS, the mean preoperative score was 41.70(S.D = 14.99), all of 
them with a score more than 7. All the patents improved postoperatively by at least 9 points 
to reach a mean post operative score of 9.90(S.D= 5.97).The mean improvement in score was 
31.8, (p=0.00) which was also statistically significant. When we compared the mean 
improvement in SNOT 22 score, between the groups of primary surgery and revision surgery, 
there  was no statistically significant difference (p value .143) .The comparative analysis of 
 the SNOT22 score in both the groups are summarized in  Figure 23 and Table 14 given 
below. 
Fig 23 Comparison of SNOT 22 score between groups of primary FESS and revision fess
 
Table 14: Comparison of SNOT 22 score between groups of primary FESS and revision f
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The SNOT22 questionnaire was also analysed separately in all the three domains of nasal, 
non-nasal and psychosocial domains, in both the groups of with polyps and without polyps, 
comparing the preoperative and postoperative scores. All the comparisons were statistically 
significant and are summarized in the table below. 
Table 15: Comparison of preoperative and postoperative SNOT 22 score in various domains  
 Domain of 
complaints 
Mean 
preoperative 
score 
Mean 
postoperative 
score 
p value 
Rhino sinusitis 
with polyposis 
Nasal 18.5 7.21 .00 
Non-nasal 2.82 0.37 .00 
Psychosocial 9.0 0.37 .00 
Total score 29.95 9.11 .00 
Rhino sinusitis 
Without polyposis 
Nasal 14.43 5.07 .00 
Non-nasal 3.19 0.92 .01 
Psychosocial 7.61 0.31 .00 
Total score 25.69 8.69 .01 
 
q) Comparison of preoperative and postoperative LKES scores 
Lund Kennedy endoscopic scoring done preoperatively and post-operatively at 3-6months 
follow up visit was compared. The data was analyzed and compared between the group with 
polyps and without polyps. In the group with polyps the mean preoperative score of 7.75 
improved to a mean score of 1.94. In the group without polyps also, there was a comparable 
improvement of the mean LK score from 6.14 to 2.04 postoperatively. The details of the 
analysis are summarized in the table and the figure given below. Both the groups showed 
statistically significant improvement postoperatively. 
 Table 16: Comparison of improvement in LK score in both groups of sinusitis
 Preop mean LK score
Group with 
 Polyposis n=37 
7.75 
Group without 
polyposis n=13 
6.14 
 
Fig 21 Pattern of  improvement in Endoscopic scoring in both groups of sinusitis 
Also, the Lund Kennedy endoscopic score was analysed to compare between the two groups 
of surgery, FESS done the first time and in cases of revision surgery. In the group of first 
time surgery, the mean preoperative score was 7.15 (S.D = 2.62) which improved to 1.92 
(S.D = 2.44) postoperatively. In revision FESS, the mean preoperative score 
3.38) which improved to a mean score of 2.19 (S.D = 2.7) post operatively.
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was 8.44 (S.D = 
 
 The pattern of improvement is summarized in the table and figure given below. Both the 
group of primary FESS and revision FESS showed statistically significant 
 
Table 17 .Pattern of improvement in Endoscopic Scoring in cases of Primary Vs Revision 
FESS 
 Mean preop LK score
Primary FESS 
 n=40 
7.15 
Revision FESS 
 n=10 
8.44 
 
 
 
 
 
Fig 22: Pattern of improvement in Endoscopic Scoring in cases of Primary Vs Revision FESS
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r) Improvement in individual symptoms in SNOT 22 
 
Each individual question in the SNOT22 questionnaire was analysed separately, comparing 
the preoperative and postoperative data of the 50 patients who came for follow up. Most 
common preoperative complaint was nasal block (92%), followed by sneezing (72%), runny 
nose (70%) and post nasal discharge (70%). It was observed that complaints pertaining to 
question 2 (Sneezing), question 5 (Post nasal discharge), question 21 (Sense of taste / smell) 
and question 22(Blockage / Congestion of the nose) persisted in more than 50% of the 
patients, though statistically there was significant improvement in the scores. The change in 
the preoperative and post operative complaints of each individual question is summarized in 
the table below.  (Table 18) 
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Table 18: SNOT 22 Individual Symptom : Improvement in percentage 
Qn.No  Preop:Score 
0.No 
complaint(%) 
Preop: 
Score 5. As 
bad as it 
can be (%) 
Postop:Score 
0.No such 
complaint (%) 
Postop: 
Score 5.As 
bad as it can 
be (%) 
1 Need to blow nose 21 (42%) 3  (6%) 38 (76% 1 (2%) 
2 Sneezing 14 (28%) 7 (14%) 22 (44%) 1 (2%) 
3 Runny nose 15 (30%) 7 (14%) 31 (62%) 1( 2%) 
4 Cough 28 (56%) 1 (2%) 44 (88%) 1 (2%) 
5 Postnasal discharge 15 (30%) 4 (8%) 25 (50%) 1 (2%) 
6 Thick nasal discharge 17 (34%) 5 (10%) 40 (80%) 1 (2%) 
7 Ear fullness 37 (74%) 1 (2%) 48 (96%) 0 
8 Dizziness 44 (88%) 0 48 (96%) 0 
9 Ear pain / pressure 40 (80%) 0 49 (98%) 0 
10 Facial pain/ pressure 26 (52%) 0 42 (84%) 0 
11 Difficulty falling asleep 28 (56%) 2 (4%) 43 (86%) 0 
12 Waking up at night 27 (54%) 1 (2%) 46 (92%) 0 
13 Lack of good night sleep 33 (66%) 0 44 (88%) 0 
14 Waking up tired 37 (74%) 0 48( 96%) 0 
15 Fatigue during the day 30 (60%) 1 (2%) 44( 88%) 0 
16 Reduced productivity 38 (76%) 1 (2%) 44( 88%) 0 
17 Reduced concentration 38 (76%) 0 45 (90%) 0 
18 Frustrated/restless/irritable 27 (54%) 2 (4%) 42 (84%) 1( 2%) 
19 Sad 35 (70%) 4 (8%) 43 (86%) 0 
20 Embarrassed 33 (66%) 2 (4%) 48 (96%) 0 
21 Sense of taste or smell 16 (32%) 13 (26%) 20 (40%) 2 (4%) 
22 Nasal block/Congestion 4   (8%) 23 (46%) 5 (10%) 1 (2%) 
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s) Other observations  
We had also noted that few of the patients had some extra complaints other than those 
included in the SNOT22 questionnaire. The observations are summarized in the table below. 
 
Table 19: Other preoperative complaints summarized 
Serial No: Complaint Number of patients 
1 Bleeding / blood stained nasal discharge 11 
2 Breathing difficulty 4 
3 Recurrent fever 2 
4 Halitosis 12 
5 Headache 8 
6 Epiphora 3 
7 Proptosis 2 
8 Snoring 8 
9 Ear discharge 3 
10 Dry mouth (mouth breathing) 3 
11 Parosmia 1 
  
As all the 90 patients did not come for follow up a comparative analysis of these symptoms 
could not be made. However, ear discharge had stopped in all the three patients following 
FESS. Two of the patients had developed the complaint of blood stained discharge 
postoperatively. Snoring had persisted in two of the patients, both with high BMI. 
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t) Complications and failures 
Of all the 90 patients who underwent FESS two patients had postoperative complications. 
First patient with extensive polyposis had right orbital haematoma, which was recognised on 
table and orbital decompression was done immediately. There were no visual complaints 
postoperatively. The second patient had postoperative bleeding following nasal pack removal 
the next day and nose had to be repacked. He was also managed conservatively and recovery 
was uneventful. The blood loss in all the patients were within permissible limits and none 
needed any transfusion. 
Three of the patients had recurrence of the disease and had to be planned for revision surgery 
within a year. Two of these patients had polyps and the third one was a diabetic with 
sphenoidal sinusitis in whom the mucopurulent discharge and post nasal drip persisted. 
Overall, the complication rate was low and patients were symptomatically better during the 
follow up visits. 
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                                      Discussion and conclusions: 
CRS is an apparently common condition whose diagnosis is largely symptom based with 
corroboration of diagnosis based on endoscopic and radiological findings. The exact 
prevalence of the disease is unknown and most estimates are based on hospital –based 
figures. The demographic pattern of this disease has been poorly studied in the Indian 
population. Much less is known about the outcome following FESS among adult Indian 
patients.  
 
 The present study revealed that most patients with CRS were males (63.3%). This is in 
contrast to the findings of Chen Y et al, Bhattacharya et al and Chambers et al, who found 
that CRS was more prevalent in females. Our finding that CRS was commonest in the 4
th
 to 
5
th
 decades among adult patients has been substantiated by other authors [Table 20]. 
Analysing the group of patients with CRSwNP, we found that polyps were more common in 
men with a peak incidence in the age group of 50-59 years. This was similar to the findings 
of Larsen and Tos (16). We also found that the average age of patients with polyps was 39.6 
years, which was also quite comparable to that reported in the literature (14-16) 
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    Table 20 :Comparison of demographic parameters  
Author/ year Number of patients                   Sex Distribution Mean 
Age(yrs) 
 Total CRSwNP CRSsNP Male Female  
Bhattacharya / 2007 251 86 165 111 140 42.9 
Deal et al /2004 201 78 123 104 97 49 
Timothy et al/ 2005 119 43 76 45 74 47.1 
Giger et al / 2004 77 NM* 77 37 36 42.7 
Khalid et al / 2004 150 NM* NM* 61 89 NM* 
Our study 90 69 21 57 33 41.17 
 
*= Not mentioned 
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Patients with sinusitis are known to have comorbidities. In the present study we found that 
hypertension was the commonest comorbidity (24.4%). Patients with diabetes mellitus 
(14.4%) were less frequently seen. Only 10% of our patients had bronchial asthma. Chandra 
et al found a higher prevalence of CRS among asthmatics (18%) compared to those with 
hypertension (4.4%). The authors found that CRSwNP was more common in bronchial 
asthma and certain  autoimmune diseases like atopic dermatitis and inflammatory bowel 
disease, suggesting that a similar immunological mechanism was involved in the 
etiopathogenesis of these diseases. The immunological mechanisms in CRS have been shown 
to be Th2 mediated with tissue eosinophilia in CRSwNP and Th1 mediated with neutrophilia 
in CRSsNP(59).In the present study, we found that 8 of 9 patients with bronchial asthma had 
CRSwNP while only 1 of these 9 patients had CRS s NP. This finding further reaffirms the 
fact that there is a higher proportion of CRSwNP phenotype among CRS patients who have 
bronchial asthma. Other authors have also commented on this phenomenon(48). The unified 
airway concept where different parts of the upper and lower airways are affected (CRS and 
bronchial asthma) does lend credence to such an association.     
 
The application of a QOL instrument like SNOT 22 in the preoperative evaluation of patients 
with CRS enabled us to make valid, objective comparisons of preoperative and postoperative 
status of these patients using the derived scores. Chambers et al used a visual analogue scale 
ranging from 1 to 5, dividing those who had “moderate to major benefit” (scores of 4 or 5) 
into one group and those with lower scores into another group(61). As specific nasal, non-
nasal and functional benefit is not assessed in this form of evaluation, comparison of results is 
made difficult. Giger et al used symptom specific evaluation to assess severity of symptoms 
pre and postoperatively(58). Here again, the lack of inclusion of data on functional 
impairment does not allow assessment of the impact of CRS on the patient’s QOL.  
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As QOL instruments assess some non-disease specific symptoms in addition to disease 
specific symptoms, it is essential to acquire normative data. In this connection, the SNOT 20 
QOL has been administered to adult individuals with no sinonasal diseases to ascertain 
cutoffs for patients with CRS (23). The authors noted that the scores ranged from 0 to 50 with 
a median score of 7. They suggested that a score of 7 be used to separate normal from 
diseased patients. In the present study, 98.9% of our patients had SNOT 22 scores exceeding 
7, making it evident that the underlying disease process had significantly affected these 
patients necessitating surgery. The mean preoperative SNOT 22 score of patients with CRS in 
our study was 29.27 (S.D=13.5 ), which was lower than the preoperative SNOT22 score 
reported in the National comparative audit by Hopkins et al, of 40.9 (S.D.=19.9)(37). Further, 
in contrast to the observation made by Hopkins et al, we had a higher preoperative mean 
score in the group with polyps in comparison to that of the group without polyps, though the 
difference was not statistically significant. When comparing patient with CRSwNP and 
CRSsNP who underwent FESS, Deal et al (54) also found higher SNOT-20 scores (mean 
=32.2+/-1.2) in patients with CRSwNP compared to those with CRSsNP whose mean SNOT 
20 scores were 26.5 (SD=1.0).  Using the CSS QOL instrument, Smith et al also described a 
higher QOL score preoperatively in patients with CRSwNP compared to those with 
CRSsNP(56). These findings were also noted in the present study. 
 
 The greater endoscopic (Lund Kennedy) and CT scan (Lund Mackay) scores in patients with 
CRSwNP than in those with CRSsNP that was seen in our study has also been described by 
other authors (43,56,62). The edema and bulk of the polyps filling the nasal cavities and 
paranasal sinuses in patients with CRSwNP are responsible for the higher endoscopic and CT 
scan scores in thses patients. 
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Postoperative improvement in QOL and endoscopic scores following FESS have been 
described by several authors (37,43,51,54,56,61-63).  In the present study, there was 
significant improvement in SNOT 22 scores, with a mean improvement of 19.8 points. The 
mean improvement in scores was higher in the groups with polyps and the results were 
comparable to the Hopkins study (37). Sub analysis of SNOT 22 in its three domains also 
reflected comparable results in both the groups. The efficacy of FESS is related to both the 
benefit of removing inflammatory tissue and reduction in antigen load as well as improved 
sinus ventilation and mucociliary clearance. 
 
Most authors report symptomatic improvement in patients who have undergone FESS. Using 
symptom specific improvement as a criterion, Chester et al  pooled data from 21 studies most 
of which used a visual analogue score for assessment(63). Their analysis revealed that while 
all symptoms improved postoperatively, nasal obstruction was the symptom that showed the 
greatest change, followed by headache and postnasal drip. In the present study, we found a 
similar significant improvement in nasal obstruction, although symptoms of sneezing and 
nasal discharge often persisted in patients with nasal allergy. An interesting finding in the 
present study was the improvement in many non-nasal symptoms after FESS. This included 
ear discharge and epistaxis. Ehnage et al showed a reduction in asthma symptom severity 
postoperatively(64). Giger et al, however, found that non-asthmatics had a better outcome 
after FESS than asthmatics(58). 
In the present study we noted that with the improved SNOT 22 scores in all patients with 
CRS, a corresponding improvement in the postoperative endoscopic Lund Kennedy scores 
occurred. Giger et al also found a strong correlation between postoperative endoscopic scores 
and symptom scores (58). However, they noted that some patients with lower symptom 
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scores had residual/recurrent polyps in the ethmoid cavities at follow up.  In contrast, 
Kennedy found no correlation between symptoms and endoscopic scores (60). 
 
 
Revision surgery is occasionally required in patients with CRS, although the rate of revision 
surgery varies widely from centre to centre (Table 21). In the present study, while 40 patients 
with follow up had primary FESS, 10 had revision FESS. The patients with revision FESS 
appeared to have higher preoperative SNOT 22 scores and greater postoperative 
improvement. Similar findings were noted by others (55,52). 
 
Lund et al showed a sustained improvement in SNOT 22 scores upto 5 years after surgery in 
revision cases. Most studies have shown that in patients undergoing revision FESS, CRSwNP 
is more common than CRSsNP (5,37). This was the case in our study too where out of the 16 
revision FESS cases which we had included in our study, 14 of them (87.5%) had polyps. 
The reason for this is that the underlying mechanisms that predispose to polyposis like 
allergic rhinitis and allergic fungal sinusitis or cystic fibrosis are operative and unless 
simultaneous measures to treat these conditions are in place, polyposis will inevitably recur. 
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  Table 21:   Comparative analysis of revision FESS for CRS 
Author/year Number of patients Revision rate 
  CRSwNP CRSsNP at 12 months 
Deal et al/2004 201 78 123 4.5% 
Hopkins/ 2006 3128   3.7% 
Bhattacharya/2007 251 86 165 4.3% 
Giger et al/2004   77 15% 
Our study 90 69 21 6% 
 
 
 
 
 
 
 
Intraoperative and postoperative complications of FESS are largely dependent on the surgical 
skills of the surgeon. Table 22 compares complication rates in a few studies that have 
addressed this issue. Our complication rate of 2.2% compares favourably with the studies 
listed. Clearly, where a large number of surgeons of varing experience and calibre are 
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involved in performing FESS, a higher complication rate may be observed that in situations 
where one or a few specialised surgeons alone operate on all the cases.  
Table 22 : Comparative analysis of complication rates following FESS 
  
Author/year Number of patients Complication rate 
Nair et al/2011        90      11.2% 
Hopkins/2006        3128       6.9% 
Lee et al/2007        125        1.4% 
Lund/1994        650        0.3% 
Our study        90        2.2% 
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In conclusion, FESS is an effective procedure for the management of CRSwNP and CRSsNP. 
The subjective as well as objective outcomes are good in cases of revision surgery as well as 
in those with polyps. It is also a safe procedure in experienced hands. However, there is still a 
need for more randomised controlled studies with long term follow up comparing different 
surgical techniques in FESS as well as comparison of FESS with  medical therapy to clearly 
outline a recommendation for the management of both cases of CRSwNP and CRSsNP. 
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Annexures: 
 
 
                                     a.        Informed consent form  
 
Study Title: Outcome of FESS in chronic sinusitis with or without polyposis         
 
Subject’s Name:                                                             Study no: 
Father’s / Husband’s name:  
Date of Birth / Age :                                                       Hospital no.  
  
Consent given by:  
 
I. I confirm that I have read and understood the information sheet dated _________ for the 
above study and have had the opportunity to ask questions [ ] 
II. I understand that my participation in the study is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my medical care or legal rights being 
affected. [ ] 
III. I understand that the Sponsor of the clinical trial, others working on the Sponsor’s behalf, 
the Ethics Committee and the regulatory authorities will not need my permission to look at 
my health records both in respect of the current study and any further research that may be 
conducted in relation to it, even if  I withdraw from the trial, I agree to this access. However, 
I understand that my identity will not be revealed in any information released to third parties 
or published. [ ]  
 
IV. I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) [ ]  
V. I agree  to take part in the above study. [ ]  
 
 
Signature (or Thumb impression) of the Subject/     : 
Legally Acceptable Representative   
 
Signatory’s Name: _________________________________ Date: _____/_____/______ 
 
Signature of the Investigator: ________________________ Date: _____/_____/______ 
Study Investigator’s Name: _________________________  
 
Signature of the Witness: ___________________________ Date:_____/_____/_______ 
Name of the Witness: _____________________________ 
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b.   PROFORMA  FOR STUDY ON OUTCOME OF FESS IN CHRONIC SINUSITIS 
 Date:                                          Study number: 
Patient name :                                                                  Age :                Sex :  
Hospital number                                                              Admitting Unit :  
Present Address:  
  
 
Telephone number :                                                        Cell number:Email ID :  
Complaints: Nasal blockage / obstruction /congestion /nasal discharge (ant / post) 
                    Facial pain / pressure. Reduction / loss of smell  
Total duration of complaints:                                     Allergic complaints: 
Preop Antibiotic:                                                        Steroids:Oral /Nasal spray 
Comorbid illnesses:                                                    IgE: 
DIAGNOSIS : CHRONIC RHINOSINUSITIS WITH POLYPOSIS /WITHOUT POLYPOSIS 
SURGERY:                                                                                Biopsy:                                   Fungal culture: 
Follow up dates:                    
LUND KENNEDY ENDOSCOPIC SCORING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total score:  right      left 
 
 
 
 
 
 
 
 
  
 
 
 
Left: 
 
         0           1            2  
Polyps  absent In MM Beyond MM 
Discharge absent thin Thick/purulent 
Edema absent Mild  Severe 
Scarring absent Mild Severe 
Crusting absent Mild  Severe 
 
Right 
 
 
         0           1            2 
Polyps  absent In MM Beyond MM 
Discharge absent thin Thick/purulent 
Edema absent Mild  Severe 
Scarring absent Mild Severe 
Crusting absent Mild  Severe 
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4: Name  and No:                                                 Date                                                                            Study no: 
 Preop/post op  
                                                                                                                  
: Sino-Nasal Outcome Test-22 Questionnaire                                                                                                              
Please rate complaints given below on how ‘bad’ it is by circling the number that corresponds with how you feel using this scale .No problem 0     Very mild problem 
1  Mild or slight problem 2   Moderate problem 3  Severe problem 4  Problem as bad as it can be 5) Kindly tick and mark 3 worst complaints 
 
Extra complaints if any: 
Post op steroids:oral/ spray:                                                            Duration 
Complication 
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     Proforma for post.op patients 
 
Study:OUTCOME OF FESS IN CHRONIC SINUSITIS                       Study 
no: 
 
Name:                                       Hosp.No:                                                 Date:                                                                                                                             
Post op    ------     months               Date of surgery:     
Diagnosis:             
 
LUND KENNEDY ENDOSCOPIC SCORING 
 
 
 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total score:                      Right                                   Left 
 
 
 
 
 
 
Right 
 
 
         0           1            2 
Polyps  absent In MM Beyond MM 
Discharge absent thin Thick/purulent 
Edema absent Mild  Severe 
Scarring absent Mild Severe 
Crusting absent Mild  Severe 
 
Left: 
 
         0           1            2 
Polyps  absent In MM Beyond MM 
Discharge absent thin Thick/purulent 
Edema absent Mild  Severe 
Scarring absent Mild Severe 
Crusting absent Mild  Severe 
91 
 
Name and number:                                                                    Study number :                 
 
                           Sino-Nasal Outcome Test-22 Questionnaire                                                               
Please rate complaints given below on how ‘bad’ it is by circling the number that corresponds with how you feel 
using this scale .No problem 0     Very mild problem 1  Mild or slight problem 2   Moderate problem 3  
Severe problem 4  Problem as bad as it can be 5) Kindly tick and mark 3 worst complaints 
1. Need to blow nose               -------        0       1          2            3         4           5 
2. Sneezing                              -------        0       1          2            3         4           5 
 
3. Runny nose                          -------        0       1          2            3         4           5 
 
4. Cough                                   -------        0       1          2            3          4           5 
 
5. Post nasal discharge                -------        0       1          2            3         4           5 
                    
6. Thick nasal discharge          -------        0        1          2            3         4           5 
                  
7. Ear fullness                            -------        0       1          2            3         4           5 
                              
8. Dizziness                                -------        0       1          2            3         4           5 
                                   
9. Ear pain/pressure                   -------        0       1          2            3         4           5 
                         
10. Facial pain/pressure             -------        0       1          2            3         4           5 
 
11. Difficulty falling asleep          -------        0       1          2            3         4           5 
  
12. Waking up at night                -------        0       1          2            3         4           5 
 
13. Lack of a good night’s sleep -------        0       1          2            3         4           5 
 
14. Waking up tired                     -------        0       1          2            3         4           5 
 
15. Fatigue during the day           -------        0       1          2            3         4           5 
 
16. Reduced productivity             -------        0       1          2            3         4          5 
 
17. Reduced concentration          -------        0       1          2            3         4           5 
 
18. Frustrated/restless/irritable     -------        0       1          2            3         4           5 
  
19. Sad                                         -------        0       1          2            3         4         5 
 
20. Embarrassed                          -------        0       1          2            3         4           5 
 
21. Sense of taste/smell               -------        0       1          2            3         4           5 
  
22. Blockage/congestion of nose   -------        0       1          2            3         4           5 
 Total:                                                                                                                                 Grand total 
 
                                          
Any other complaint: 
Any new complaint: 
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